{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:33:51Z","timestamp":1790696031146,"version":"4.1.0"},"reference-count":138,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T00:00:00Z","timestamp":1600214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2020R1C1C1009348"],"award-info":[{"award-number":["2020R1C1C1009348"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"reynolds and ryan families chair fund in translational cancer","award":["."],"award-info":[{"award-number":["."]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>The tumor suppressor p53 acts as a transcription factor that regulates the expression of a number of genes responsible for DNA repair, cell cycle arrest, metabolism, cell migration, angiogenesis, ferroptosis, senescence, and apoptosis. It is the most commonly silenced or mutated gene in cancer, as approximately 50% of all types of human cancers harbor TP53 mutations. Activation of p53 is detrimental to normal cells, thus it is tightly regulated via multiple mechanisms. One of the recently identified regulators of p53 is RNA-binding motif protein 10 (RBM10). RBM10 is an RNA-binding protein frequently deleted or mutated in cancer cells. Its loss of function results in various deformities, such as cleft palate and malformation of the heart, and diseases such as lung adenocarcinoma. In addition, RBM10 mutations are frequently observed in lung adenocarcinomas, colorectal carcinomas, and pancreatic ductal adenocarcinomas. RBM10 plays a regulatory role in alternative splicing. Several recent studies not only linked this splicing regulation of RBM10 to cancer development, but also bridged RBM10\u2032s anticancer function to the p53 pathway. This review will focus on the current progress in our understanding of RBM10 regulation of p53, and its role in p53-dependent cancer prevention.<\/jats:p>","DOI":"10.3390\/cells9092107","type":"journal-article","created":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T10:30:12Z","timestamp":1600252212000},"page":"2107","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["RBM10, a New Regulator of p53"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5644-5960","authenticated-orcid":false,"given":"Ji Hoon","family":"Jung","sequence":"first","affiliation":[{"name":"College of Korean Medicine, Kyung Hee University, Seoul 02447, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3910-5611","authenticated-orcid":false,"given":"Hyemin","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Tulane University School of Medicine, New Orleans, LA 70112, USA"},{"name":"Tulane Cancer Center, Tulane University School of Medicine, New Orleans, LA 70112, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelya X","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Tulane University School of Medicine, New Orleans, LA 70112, USA"},{"name":"Tulane Cancer Center, Tulane University School of Medicine, New Orleans, LA 70112, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9285-7209","authenticated-orcid":false,"given":"Hua","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Tulane University School of Medicine, New Orleans, LA 70112, USA"},{"name":"Tulane Cancer Center, Tulane University School of Medicine, New Orleans, LA 70112, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,9,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.pharmthera.2017.03.013","article-title":"Reviving the guardian of the genome: Small molecule activators of p53","volume":"178","author":"Nguyen","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/jmcb\/mjz079","article-title":"Legends of p53: Untold four-decade stories","volume":"11","author":"Lu","year":"2019","journal-title":"J. Mol. Cell Biol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1042\/BJ20150517","article-title":"Regulation of the p53 response and its relationship to cancer","volume":"469","author":"Meek","year":"2015","journal-title":"Biochem. J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ccr.2009.09.024","article-title":"Signaling to p53: Ribosomal proteins find their way","volume":"16","author":"Zhang","year":"2009","journal-title":"Cancer Cell"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.cell.2017.08.028","article-title":"Putting p53 in Context","volume":"170","author":"Kastenhuber","year":"2017","journal-title":"Cell"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Jung, J.H., Lee, H., Kim, J.H., Sim, D.Y., Ahn, H., Kim, B., Chang, S., and Kim, S.H. (2019). p53-Dependent Apoptotic Effect of Puromycin via Binding of Ribosomal Protein L5 and L11 to MDM2 and its Combination Effect with RITA or Doxorubicin. Cancers, 11.","DOI":"10.3390\/cancers11040582"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrm2147","article-title":"p53 in health and disease","volume":"8","author":"Vousden","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.cell.2009.04.037","article-title":"Blinded by the Light: The Growing Complexity of p53","volume":"137","author":"Vousden","year":"2009","journal-title":"Cell"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1126\/science.1092734","article-title":"Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis","volume":"303","author":"Chipuk","year":"2004","journal-title":"Science"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1523\/JNEUROSCI.4041-04.2005","article-title":"Noxa is a critical mediator of p53-dependent motor neuron death after nerve injury in adult mouse","volume":"25","author":"Hirayama","year":"2005","journal-title":"J. Neurosci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/ncb1123","article-title":"Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex","volume":"6","author":"Leu","year":"2004","journal-title":"Nat. Cell Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cell.2006.05.034","article-title":"DRAM, a p53-induced modulator of autophagy, is critical for apoptosis","volume":"126","author":"Crighton","year":"2006","journal-title":"Cell"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/nature07986","article-title":"Cytoplasmic functions of the tumour suppressor p53","volume":"458","author":"Green","year":"2009","journal-title":"Nature"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0092-8674(93)90500-P","article-title":"WAF1, a potential mediator of p53 tumor suppression","volume":"75","author":"Tokino","year":"1993","journal-title":"Cell"},{"key":"ref_15","first-page":"5187","article-title":"p21 is necessary for the p53-mediated G1 arrest in human cancer cells","volume":"55","author":"Waldman","year":"1995","journal-title":"Cancer Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"19035","DOI":"10.1073\/pnas.0910009106","article-title":"p21CIP1 attenuates Ras- and c-Myc-dependent breast tumor epithelial mesenchymal transition and cancer stem cell-like gene expression in vivo","volume":"106","author":"Liu","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e8261","DOI":"10.7717\/peerj.8261","article-title":"Significance of TP53 mutation in bladder cancer disease progression and drug selection","volume":"7","author":"Wu","year":"2019","journal-title":"PeerJ"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41418-018-0126-3","article-title":"TP53 gain-of-function mutation promotes inflammation in glioblastoma","volume":"26","author":"Ham","year":"2019","journal-title":"Cell Death Differ."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1158\/1078-0432.CCR-19-2485","article-title":"PI3K Inhibitors Curtail MYC-dependent Mutant p53 Gain-of-function in Head and Neck Squamous Cell Carcinoma","volume":"26","author":"Ganci","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.molcel.2017.11.006","article-title":"Mutant p53 Gains Its Function via c-Myc Activation upon CDK4 Phosphorylation at Serine 249 and Consequent PIN1 Binding","volume":"68","author":"Liao","year":"2017","journal-title":"Mol. Cell."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1006\/geno.1996.0022","article-title":"A novel gene, DXS8237E, lies within 20 kb upstream of UBE1 in Xp11.23 and has a different X inactivation status","volume":"31","author":"Coleman","year":"1996","journal-title":"Genomics"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1006\/geno.1999.5878","article-title":"An evolutionary rearrangement of the Xp11.3-11.23 region in 3p21.3, a region frequently deleted in a variety of cancers","volume":"60","author":"Timmer","year":"1999","journal-title":"Genomics"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1002\/ajmg.a.34190","article-title":"Long-term survival in TARP syndrome and confirmation of RBM10 as the disease-causing gene","volume":"155A","author":"Gripp","year":"2011","journal-title":"Am. J. Med. Genet. A"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/emmm.201302663","article-title":"Integrative analysis revealed the molecular mechanism underlying RBM10-mediated splicing regulation","volume":"5","author":"Wang","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.febslet.2014.01.052","article-title":"RBM10 regulates alternative splicing","volume":"588","author":"Inoue","year":"2014","journal-title":"FEBS Lett."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1042\/BC20070142","article-title":"S1-1 nuclear domains: Characterization and dynamics as a function of transcriptional activity","volume":"100","author":"Inoue","year":"2008","journal-title":"Biol. Cell"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.molcel.2008.08.008","article-title":"RBM5\/Luca-15\/H37 regulates Fas alternative splice site pairing after exon definition","volume":"32","author":"Bonnal","year":"2008","journal-title":"Mol. Cell"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Loiselle, J.J., Roy, J.G., and Sutherland, L.C. (2017). RBM10 promotes transformation-associated processes in small cell lung cancer and is directly regulated by RBM5. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0180258"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"8524","DOI":"10.1093\/nar\/gkx508","article-title":"Autoregulation of RBM10 and cross-regulation of RBM10\/RBM5 via alternative splicing-coupled nonsense-mediated decay","volume":"45","author":"Sun","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1016\/j.celrep.2018.08.077","article-title":"A Splicing-Independent Function of RBM10 Controls Specific 3\u2019 UTR Processing to Regulate Cardiac Hypertrophy","volume":"24","author":"Mohan","year":"2018","journal-title":"Cell Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.ajhg.2010.04.007","article-title":"Massively parallel sequencing of exons on the X chromosome identifies RBM10 as the gene that causes a syndromic form of cleft palate","volume":"86","author":"Johnston","year":"2010","journal-title":"Am. J. Hum. Genet."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/kjm2.12127","article-title":"Alternative splicing of VEGFA is regulated by RBM10 in endometrial cancer","volume":"36","author":"Dou","year":"2020","journal-title":"Kaohsiung J. Med. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1101\/gr.147546.112","article-title":"A broadly applicable high-throughput screening strategy identifies new regulators of Dlg4 (Psd-95) alternative splicing","volume":"23","author":"Zheng","year":"2013","journal-title":"Genome Res."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Sutherland, L.C., Thibault, P., Durand, M., Lapointe, E., Knee, J.M., Beauvais, A., Kalatskaya, I., Hunt, S.C., Loiselle, J.J., and Roy, J.G. (2017). Splicing arrays reveal novel RBM10 targets, including SMN2 pre-mRNA. BMC Mol. Biol., 18.","DOI":"10.1186\/s12867-017-0096-x"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.molcel.2013.11.010","article-title":"RBM5, 6, and 10 differentially regulate NUMB alternative splicing to control cancer cell proliferation","volume":"52","author":"Bechara","year":"2013","journal-title":"Mol. Cell"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.abb.2009.06.002","article-title":"The heterogenous nuclear riboprotein S1-1 regulates AT1 receptor gene expression via transcriptional and posttranscriptional mechanisms","volume":"488","author":"Mueller","year":"2009","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Yamada, H., Tsutsumi, K., Nakazawa, Y., Shibagaki, Y., Hattori, S., and Ohta, Y. (2016). Src Family Tyrosine Kinase Signaling Regulates FilGAP through Association with RBM10. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0146593"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1002\/jcb.26644","article-title":"RBM10: Harmful or helpful-many factors to consider","volume":"119","author":"Loiselle","year":"2018","journal-title":"J. Cell Biochem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/cdd.2017.169","article-title":"How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression?","volume":"25","author":"Aubrey","year":"2018","journal-title":"Cell Death Differ."},{"key":"ref_40","first-page":"2851","article-title":"p53 cellular tumor antigen: Analysis of mRNA levels in normal adult tissues, embryos, and tumors","volume":"5","author":"Rogel","year":"1985","journal-title":"Mol. Cell Biol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1101\/gad.1941710","article-title":"The Mdm2-p53 relationship evolves: Mdm2 swings both ways as an oncogene and a tumor suppressor","volume":"24","author":"Manfredi","year":"2010","journal-title":"Genes Dev."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/387296a0","article-title":"Mdm2 promotes the rapid degradation of p53","volume":"387","author":"Haupt","year":"1997","journal-title":"Nature"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0014-5793(97)01480-4","article-title":"Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53","volume":"420","author":"Honda","year":"1997","journal-title":"FEBS Lett."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"8945","DOI":"10.1074\/jbc.275.12.8945","article-title":"Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53","volume":"275","author":"Fang","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_45","first-page":"1001","article-title":"The MDM2-p53 interaction","volume":"1","author":"Moll","year":"2003","journal-title":"Mol. Cancer Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/sj.onc.1202281","article-title":"Comparative study of the p53-mdm2 and p53-MDMX interfaces","volume":"18","author":"Bottger","year":"1999","journal-title":"Oncogene"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/embo-reports\/kve227","article-title":"Mdmx stabilizes p53 and Mdm2 via two distinct mechanisms","volume":"2","author":"Stad","year":"2001","journal-title":"EMBO Rep."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/sj.emboj.7601465","article-title":"The Mdm2 RING domain C-terminus is required for supramolecular assembly and ubiquitin ligase activity","volume":"26","author":"Poyurovsky","year":"2007","journal-title":"EMBO J."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"23725","DOI":"10.1074\/jbc.M110.213868","article-title":"MdmX protein is essential for Mdm2 protein-mediated p53 polyubiquitination","volume":"286","author":"Wang","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"38189","DOI":"10.1074\/jbc.274.53.38189","article-title":"Stabilization of the MDM2 oncoprotein by interaction with the structurally related MDMX protein","volume":"274","author":"Sharp","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1128\/MCB.20.3.1001-1007.2000","article-title":"MdmX protects p53 from Mdm2-mediated degradation","volume":"20","author":"Jackson","year":"2000","journal-title":"Mol. Cell Biol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nrc3430","article-title":"MDM2, MDMX and p53 in oncogenesis and cancer therapy","volume":"13","author":"Wade","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ydbio.2017.01.014","article-title":"Monitoring p53 by MDM2 and MDMX is required for endocrine pancreas development and function in a spatio-temporal manner","volume":"423","author":"Zhang","year":"2017","journal-title":"Dev. Biol."},{"key":"ref_54","first-page":"88","article-title":"MDM2 and MDMX: Alone and together in regulation of p53","volume":"1","author":"Shadfan","year":"2012","journal-title":"Transl Cancer Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/jmcb\/mjx006","article-title":"Mouse modelling of the MDM2\/MDMX-p53 signalling axis","volume":"9","author":"Tackmann","year":"2017","journal-title":"J. Mol. Cell Biol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"12001","DOI":"10.1073\/pnas.1102309108","article-title":"The p53 inhibitors MDM2\/MDMX complex is required for control of p53 activity in vivo","volume":"108","author":"Huang","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/sj.cdd.4402309","article-title":"Structure of the MDM2\/MDMX RING domain heterodimer reveals dimerization is required for their ubiquitylation in trans","volume":"15","author":"Linke","year":"2008","journal-title":"Cell Death Differ."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"33065","DOI":"10.1074\/jbc.M110.115113","article-title":"Turning the RING domain protein MdmX into an active ubiquitin-protein ligase","volume":"285","author":"Iyappan","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1093\/carcin\/bgi122","article-title":"Complicating the complexity of p53","volume":"26","author":"Yee","year":"2005","journal-title":"Carcinogenesis"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1046\/j.1432-1327.2001.02225.x","article-title":"Post-translational modifications and activation of p53 by genotoxic stresses","volume":"268","author":"Appella","year":"2001","journal-title":"Eur. J. Biochem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/jmcb\/mjz060","article-title":"p53 modifications: Exquisite decorations of the powerful guardian","volume":"11","author":"Liu","year":"2019","journal-title":"J. Mol. Cell Biol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s13238-011-1063-9","article-title":"The impact of acetylation and deacetylation on the p53 pathway","volume":"2","author":"Brooks","year":"2011","journal-title":"Protein Cell"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/0470862637.ch14","article-title":"Dynamics of the p53 acetylation pathway","volume":"259","author":"Gu","year":"2004","journal-title":"Novartis Found. Symp."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0092-8674(00)80521-8","article-title":"Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain","volume":"90","author":"Gu","year":"1997","journal-title":"Cell"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"50607","DOI":"10.1074\/jbc.C200578200","article-title":"Acetylation of p53 inhibits its ubiquitination by Mdm2","volume":"277","author":"Li","year":"2002","journal-title":"J. Biol Chem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/42972","article-title":"Synergistic activation of transcription by CBP and p53","volume":"387","author":"Gu","year":"1997","journal-title":"Nature"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"19581","DOI":"10.1074\/jbc.M113.476606","article-title":"Negative regulation of the acetyltransferase TIP60-p53 interplay by UHRF1 (ubiquitin-like with PHD and RING finger domains 1)","volume":"288","author":"Dai","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"12547","DOI":"10.1073\/pnas.97.23.12547","article-title":"MDM2 inhibits p300-mediated p53 acetylation and activation by forming a ternary complex with the two proteins","volume":"97","author":"Kobet","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nature737","article-title":"Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization","volume":"416","author":"Li","year":"2002","journal-title":"Nature"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1093\/emboj\/20.6.1331","article-title":"p300\/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2","volume":"20","author":"Ito","year":"2001","journal-title":"EMBO J."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.molcel.2016.08.027","article-title":"Direct Interaction of c-Myc with Smad2 and Smad3 to Inhibit TGF-beta-Mediated Induction of the CDK Inhibitor p15(Ink4B)","volume":"63","author":"Feng","year":"2016","journal-title":"Mol. Cell."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1535-6108(02)00102-2","article-title":"The RB and p53 pathways in cancer","volume":"2","author":"Sherr","year":"2002","journal-title":"Cancer Cell"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0092-8674(00)81401-4","article-title":"ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways","volume":"92","author":"Zhang","year":"1998","journal-title":"Cell"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/35060032","article-title":"Cytoplasmic localization of p21Cip1\/WAF1 by Akt-induced phosphorylation in HER-2\/neu-overexpressing cells","volume":"3","author":"Zhou","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1038\/sj.onc.1205276","article-title":"Phosphorylation of HDM2 by Akt","volume":"21","author":"Ashcroft","year":"2002","journal-title":"Oncogene"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/sj.onc.1205181","article-title":"Cross-talk between Akt, p53 and Mdm2: Possible implications for the regulation of apoptosis","volume":"21","author":"Gottlieb","year":"2002","journal-title":"Oncogene"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"21843","DOI":"10.1074\/jbc.M109745200","article-title":"Akt enhances Mdm2-mediated ubiquitination and degradation of p53","volume":"277","author":"Ogawara","year":"2002","journal-title":"J. Biol Chem."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"a000950","DOI":"10.1101\/cshperspect.a000950","article-title":"Posttranslational modification of p53: Cooperative integrators of function","volume":"1","author":"Meek","year":"2009","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1101\/gad.886901","article-title":"ATM-dependent phosphorylation of Mdm2 on serine 395: Role in p53 activation by DNA damage","volume":"15","author":"Maya","year":"2001","journal-title":"Genes Dev."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3389\/fcell.2020.00233","article-title":"Targeting USP7-Mediated Deubiquitination of MDM2\/MDMX-p53 Pathway for Cancer Therapy: Are We There Yet?","volume":"8","author":"Qi","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejmech.2019.05.018","article-title":"The past, present and future of potential small-molecule drugs targeting p53-MDM2\/MDMX for cancer therapy","volume":"176","author":"Liu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_82","first-page":"173","article-title":"Nutlin-3, A p53-Mdm2 Antagonist for Nasopharyngeal Carcinoma Treatment","volume":"18","year":"2018","journal-title":"Mini Rev. Med. Chem."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/ijc.29663","article-title":"Transcription factors that interact with p53 and Mdm2","volume":"138","author":"Inoue","year":"2016","journal-title":"Int. J. Cancer"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"9608","DOI":"10.1128\/MCB.25.21.9608-9620.2005","article-title":"DNA damage-induced phosphorylation of MdmX at serine 367 activates p53 by targeting MdmX for Mdm2-dependent degradation","volume":"25","author":"Okamoto","year":"2005","journal-title":"Mol. Cell Biol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/sj.emboj.7601032","article-title":"Regulation of MDMX nuclear import and degradation by Chk2 and 14-3-3","volume":"25","author":"LeBron","year":"2006","journal-title":"EMBO J."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"6819","DOI":"10.1128\/MCB.00562-06","article-title":"Differential roles of ATM- and Chk2-mediated phosphorylations of Hdmx in response to DNA damage","volume":"26","author":"Pereg","year":"2006","journal-title":"Mol. Cell Biol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.cub.2004.07.051","article-title":"Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization","volume":"14","author":"Jin","year":"2004","journal-title":"Curr. Biol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1593\/tlo.09250","article-title":"Targeting p53 for Novel Anticancer Therapy","volume":"3","author":"Wang","year":"2010","journal-title":"Transl Oncol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1128\/MCB.20.9.3224-3233.2000","article-title":"Stress signals utilize multiple pathways to stabilize p53","volume":"20","author":"Ashcroft","year":"2000","journal-title":"Mol. Cell Biol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"8052","DOI":"10.1074\/jbc.M610621200","article-title":"5-fluorouracil activation of p53 involves an MDM2-ribosomal protein interaction","volume":"282","author":"Sun","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"12387","DOI":"10.1074\/jbc.M801387200","article-title":"Mycophenolic acid activation of p53 requires ribosomal proteins L5 and L11","volume":"283","author":"Sun","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1038\/sj.emboj.7600247","article-title":"Essential role of ribosomal protein L11 in mediating growth inhibition-induced p53 activation","volume":"23","author":"Bhat","year":"2004","journal-title":"EMBO J."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1093\/nar\/gkq1117","article-title":"PAK1IP1, a ribosomal stress-induced nucleolar protein, regulates cell proliferation via the p53-MDM2 loop","volume":"39","author":"Yu","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"44475","DOI":"10.1074\/jbc.M403722200","article-title":"Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5","volume":"279","author":"Dai","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S1535-6108(03)00134-X","article-title":"Regulation of HDM2 activity by the ribosomal protein L11","volume":"3","author":"Lohrum","year":"2003","journal-title":"Cancer Cell"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"90651","DOI":"10.18632\/oncotarget.21544","article-title":"Cancer-mutated ribosome protein L22 (RPL22\/eL22) suppresses cancer cell survival by blocking p53-MDM2 circuit","volume":"8","author":"Cao","year":"2017","journal-title":"Oncotarget"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"7654","DOI":"10.1128\/MCB.24.17.7654-7668.2004","article-title":"Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition","volume":"24","author":"Dai","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"6544","DOI":"10.1093\/nar\/gkq536","article-title":"Negative regulation of HDM2 to attenuate p53 degradation by ribosomal protein L26","volume":"38","author":"Zhang","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/onc.2012.63","article-title":"Ribosomal protein S14 unties the MDM2-p53 loop upon ribosomal stress","volume":"32","author":"Zhou","year":"2013","journal-title":"Oncogene"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1038\/onc.2010.569","article-title":"Ribosomal protein S27-like and S27 interplay with p53-MDM2 axis as a target, a substrate and a regulator","volume":"30","author":"Xiong","year":"2011","journal-title":"Oncogene"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1038\/onc.2013.410","article-title":"MDM2\u2019s social network","volume":"33","author":"Fahraeus","year":"2014","journal-title":"Oncogene"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1101\/gad.261792.115","article-title":"Structure of human MDM2 complexed with RPL11 reveals the molecular basis of p53 activation","volume":"29","author":"Zheng","year":"2015","journal-title":"Genes Dev."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"38264","DOI":"10.1074\/jbc.M111.277012","article-title":"Hydrophilic residues are crucial for ribosomal protein L11 (RPL11) interaction with zinc finger domain of MDM2 and p53 protein activation","volume":"286","author":"Zhang","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nrc2715","article-title":"p53 and metabolism","volume":"9","author":"Vousden","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41418-019-0387-5","article-title":"The antimalarial drug amodiaquine stabilizes p53 through ribosome biogenesis stress, independently of its autophagy-inhibitory activity","volume":"27","author":"Espinoza","year":"2020","journal-title":"Cell Death Differ."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1016\/j.febslet.2014.04.014","article-title":"p53 and ribosome biogenesis stress: The essentials","volume":"588","author":"Golomb","year":"2014","journal-title":"FEBS Lett."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.celrep.2013.08.049","article-title":"The 5S RNP couples p53 homeostasis to ribosome biogenesis and nucleolar stress","volume":"5","author":"Sloan","year":"2013","journal-title":"Cell Rep."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Jung, J.H., Lee, H.J., Kim, J.H., Sim, D.Y., Im, E., Kim, S., Chang, S., and Kim, S.H. (2020). Colocalization of MID1IP1 and c-Myc is Critically Involved in Liver Cancer Growth via Regulation of Ribosomal Protein L5 and L11 and CNOT2. Cells, 9.","DOI":"10.3390\/cells9040985"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"4916","DOI":"10.1038\/onc.2013.430","article-title":"Ribosomal proteins L5 and L11 co-operatively inactivate c-Myc via RNA-induced silencing complex","volume":"33","author":"Liao","year":"2014","journal-title":"Oncogene"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"e31275","DOI":"10.7554\/eLife.31275","article-title":"SPIN1 promotes tumorigenesis by blocking the uL18 (universal large ribosomal subunit protein 18)-MDM2-p53 pathway in human cancer","volume":"7","author":"Fang","year":"2018","journal-title":"Elife"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1128\/MCB.01662-07","article-title":"Aberrant expression of nucleostemin activates p53 and induces cell cycle arrest via inhibition of MDM2","volume":"28","author":"Dai","year":"2008","journal-title":"Mol. Cell Bio."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.4161\/cc.9.16.12605","article-title":"Nucleostemin: Another nucleolar \u201cTwister\u201d of the p53-MDM2 loop","volume":"9","author":"Lo","year":"2010","journal-title":"Cell Cycle"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1128\/MCB.00670-13","article-title":"AMP-activated protein kinase induces p53 by phosphorylating MDMX and inhibiting its activity","volume":"34","author":"He","year":"2014","journal-title":"Mol. Cell Biol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.molcel.2005.03.027","article-title":"AMP-activated protein kinase induces a p53-dependent metabolic checkpoint","volume":"18","author":"Jones","year":"2005","journal-title":"Mol. Cell"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ccr.2009.05.008","article-title":"Increased radioresistance and accelerated B cell lymphomas in mice with Mdmx mutations that prevent modifications by DNA-damage-activated kinases","volume":"16","author":"Wang","year":"2009","journal-title":"Cancer Cell"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.celrep.2016.12.086","article-title":"Protection against High-Fat-Diet-Induced Obesity in MDM2(C305F) Mice Due to Reduced p53 Activity and Enhanced Energy Expenditure","volume":"18","author":"Liu","year":"2017","journal-title":"Cell Rep."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/15476286.2016.1247148","article-title":"The RNA-binding landscape of RBM10 and its role in alternative splicing regulation in models of mouse early development","volume":"14","author":"Rodor","year":"2017","journal-title":"RNA Biol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/kjm2.12149","article-title":"miR-335 modulates Numb alternative splicing via targeting RBM10 in endometrial cancer","volume":"36","author":"Dou","year":"2020","journal-title":"Kaohsiung J. Med. Sci."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/JTO.0b013e3181c6e330","article-title":"RBM5 as a putative tumor suppressor gene for lung cancer","volume":"5","author":"Sutherland","year":"2010","journal-title":"J. Thorac. Oncol."},{"key":"ref_120","first-page":"3284","article-title":"Long noncoding RNA AFAP1-AS1 accelerates the proliferation and metastasis of prostate cancer via inhibiting RBM5 expression","volume":"23","author":"Yang","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol Sci."},{"key":"ref_121","first-page":"7201","article-title":"LncRNA AB073614 promotes the proliferation and inhibits apoptosis of cervical cancer cells by repressing RBM5","volume":"24","author":"Guo","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol Sci."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Wang, K., Ubriaco, G., and Sutherland, L.C. (2007). RBM6-RBM5 transcription-induced chimeras are differentially expressed in tumours. BMC Genom., 8.","DOI":"10.1186\/1471-2164-8-348"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.gene.2019.02.025","article-title":"RNA-binding protein RBM6 as a tumor suppressor gene represses the growth and progression in laryngocarcinoma","volume":"697","author":"Wang","year":"2019","journal-title":"Gene"},{"key":"ref_124","first-page":"467","article-title":"Functional role of RBM10 in lung adenocarcinoma proliferation","volume":"54","author":"Sun","year":"2019","journal-title":"Int. J. Oncol"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.cell.2012.08.029","article-title":"Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing","volume":"150","author":"Imielinski","year":"2012","journal-title":"Cell"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"31628","DOI":"10.1038\/srep31628","article-title":"Elucidating Genomic Characteristics of Lung Cancer Progression from In Situ to Invasive Adenocarcinoma","volume":"6","author":"Vinayanuwattikun","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/srep00161","article-title":"Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas","volume":"1","author":"Furukawa","year":"2011","journal-title":"Sci. Rep."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"6744","DOI":"10.1038\/ncomms7744","article-title":"Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets","volume":"6","author":"Witkiewicz","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.celrep.2016.10.009","article-title":"Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma","volume":"17","author":"Giannakis","year":"2016","journal-title":"Cell Rep."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"5970","DOI":"10.1158\/1078-0432.CCR-17-1183","article-title":"Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of MED12 and RBM10 as Novel Thyroid Cancer Genes Associated with Tumor Virulence","volume":"23","author":"Ibrahimpasic","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"40488","DOI":"10.1038\/srep40488","article-title":"Functional analysis reveals that RBM10 mutations contribute to lung adenocarcinoma pathogenesis by deregulating splicing","volume":"7","author":"Zhao","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/JCD.S9073","article-title":"RBM10 Modulates Apoptosis and Influences TNF-alpha Gene Expression","volume":"5","author":"Wang","year":"2012","journal-title":"J. Cell Death"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1111\/jcmm.14263","article-title":"RBM10 inhibits cell proliferation of lung adenocarcinoma via RAP1\/AKT\/CREB signalling pathway","volume":"23","author":"Jin","year":"2019","journal-title":"J. Cell Mol. Med."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/s41388-019-1034-9","article-title":"RNA-binding motif protein 10 induces apoptosis and suppresses proliferation by activating p53","volume":"39","author":"Jung","year":"2020","journal-title":"Oncogene"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1074\/jbc.M113.524413","article-title":"Rbm24, an RNA-binding protein and a target of p53, regulates p21 expression via mRNA stability","volume":"289","author":"Jiang","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s13046-018-0852-x","article-title":"RBM38 plays a tumor-suppressor role via stabilizing the p53-mdm2 loop function in hepatocellular carcinoma","volume":"37","author":"Ye","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1038\/s41388-018-0602-8","article-title":"Dysregulation of p53-RBM25-mediated circAMOTL1L biogenesis contributes to prostate cancer progression through the circAMOTL1L-miR-193a-5p-Pcdha pathway","volume":"38","author":"Yang","year":"2019","journal-title":"Oncogene"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"6761","DOI":"10.1093\/nar\/gkx225","article-title":"An RRM-ZnF RNA recognition module targets RBM10 to exonic sequences to promote exon exclusion","volume":"45","author":"Collins","year":"2017","journal-title":"Nucleic Acids Res."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/9\/9\/2107\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:10:27Z","timestamp":1760177427000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/9\/9\/2107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,16]]},"references-count":138,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9]]}},"alternative-id":["cells9092107"],"URL":"https:\/\/doi.org\/10.3390\/cells9092107","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,16]]}}}